IPI-549,
1693758-51-8,
UNII-FOF5155FMZ,
FOF5155FMZ,
IPI549,
CHEMBL3984425,
(S)-2-amino-N-(1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide,
Pyrazolo(1,5-a)pyrimidine-3-carboxamide, 2-amino-N-((1S)-1-(1,2-dihydro-8-(2-(1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-3-isoquinolinyl)ethyl)-,
Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 2-amino-N-[(1S)-1-[1,2-dihydro-8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-3-isoquinolinyl]ethyl]-,
GTPL9563,
pi3k-gamma Inhibitor IPI-549,
SCHEMBL16629991,
IPI 549,
2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide,
EX-A1057,
BDBM50192880,
MFCD30533720,
s8330,
ZINC584906867,
ACN-051238,
CS-6106,
compound 26 [PMID: 27660692],
AC-29898,
HY-100716,
A16332,
(S)-2-Amino-N-(1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2- dihydroisoquinolin-3-yl)ethyl)pyrazolo(1,5-a)pyrimidine-3-carboxamide,
IPI-549, 98%, a potent and selective PI3Kgamma Inhibitor - 25MG 25mg,